Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : TVGN-489
Therapeutic Area : Infections and Infectious Diseases
Study Phase : IND Enabling
Sponsor : Tevogen Bio
Deal Size : Undisclosed
Deal Type : Partnership
Details : Experts from both entities will collaborate at BioCentriq’s state-of-the art GMP facilities to produce Tevogen’s proprietary COVID-19 targeted T cells.
Product Name : TVGN-489
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
March 15, 2021
Lead Product(s) : TVGN-489
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : IND Enabling
Sponsor : Tevogen Bio
Deal Size : Undisclosed
Deal Type : Partnership